This company develops and commercializes biologic therapies, with FDA-approved drugs targeting rare diseases such as diabetic ketoacidosis and various cancers, though it has no orphan drug designations.
0
Orphan Designations
7
FDA Approvals
4
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| cervical cancer | JOBEVNE | - | FDA Approved |
| colorectal cancer | JOBEVNE | - | FDA Approved |
| diabetic ketoacidosis | INSULIN GLARGINE | - | FDA Approved |
| renal cell carcinoma | JOBEVNE | - | FDA Approved |